Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation
- 1 January 2000
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 25 (2) , 179-184
- https://doi.org/10.1038/sj.bmt.1702121
Abstract
Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.Keywords
This publication has 13 references indexed in Scilit:
- Red cell aplasia due to host type isohemagglutinins with exuberant red cell progenitor production of donor type in an ABO-mismatched allogeneic bone marrow transplant recipientEuropean Journal of Haematology, 2009
- Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO‐incompatible allogeneic bone marrow transplantTransfusion, 1998
- Transfusion of donor‐type red cells as a single preparative treatment for bone marrow transplants with major ABO incompatibilityTransfusion, 1995
- Case Report: Isoimmune Inhibition of Erythropoiesis Following ABO-Incompatible Bone Marrow TransplantationThe Lancet Healthy Longevity, 1991
- Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation with recombinant erythropoietin [letter; comment]Blood, 1991
- Pure red cell aplasia of long duration complicating major ABO- incompatible bone marrow transplantation [see comments]Blood, 1990
- Changes in cell surface antigen expression during hemopoietic differentiationBlood, 1982
- Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusionBlood, 1982
- ABO-INCOMPATIBLE MARROW TRANSPLANTSTransplantation, 1982
- ABO-INCOMPATIBLE MARROW TRANSPLANT,STransplantation, 1978